More than half of cancer patients receive radiotherapy as a part of their cancer treatment.
DNA double-strand breaks (DSBs) are considered as the most lethal form of DNA damage …

Abstract Purpose of Review Treatment of locally advanced, unresectable non-small cell lung
cancer (NSCLC) has recently been revolutionized by the incorporation of immunotherapy to …

Purpose To test, in a single-arm, prospective, phase 2 trial, whether adding the epidermal
growth factor receptor (EGFR) tyrosine kinase inhibitor erlotinib to concurrent …

Osimertinib (AZD9291) is a third generation epidermal growth factor receptor (EGFR)
tyrosine kinase inhibitor that has demonstrated significant clinical benefits in patients with …

Thoracic radiation therapy (RT) for non-small cell lung cancers may overcome resistance to
tyrosine kinase inhibitors (TKIs). However, the risk of severe treatment-related pneumonitis …

To compare the efficacy of dendritic and cytokineinduced killer cells (DC-CIK) therapy
combined with concurrent radiochemotherapy on stage IIIB non-small cell lung cancer …

Introduction Thoracic radiotherapy (RT) for non-small cell lung cancers (NSCLCs) may
overcome resistance to tyrosine kinase inhibitors (TKIs). However, the risk of severe …

Background: Consolidation systemic therapy (ST) given after concurrent radiotherapy (RT)
and ST (RT-ST) is frequently practiced in locally advanced inoperable nonsmall cell lung …

Nonadvanced non-small-cell lung cancer (NSCLC) has a poor long-term survival from
surgery or definitive radiation that is minimally improved with induction/adjuvant …

放射治疗是治疗肿瘤的重要手段, 提高放疗疗效仍是目前肿瘤放射治疗学领域亟待解决的难题.
表皮生长因子受体(epidermal growth factor receptor, EGFR) 是ErbB 家族成员之一 …